Literature DB >> 31264107

Association between interleukin-4 and interleukin-10 single nucleotide polymorphisms and multiple sclerosis among Iraqi patients.

Milad A Al-Naseri1, Ehab D Salman2, Ali H Ad'hiah3.   

Abstract

Multiple sclerosis (MS) is a neurodegenerative autoimmune disease, in which cytokines play a prominent role. Among these cytokines are interleukin-4 (IL-4) and IL-10, which have been demonstrated to be involved in immunopathogenesis of the disease. The present case-control study inspected the association between seven single nucleotide polymorphisms (SNPs) of IL4 (IL4-1098: rs2243248, IL4-590: rs2243250, and IL4-33: rs2070874), IL4RA (IL4RA+1902: rs1801275), and IL10 (IL10-1082: rs1800896, IL10-819: rs1800871, and IL10-592: rs1800872) genes and MS in Iraqi patients. Sixty-eight clinically definite relapsing-remitting MS Iraqi patients and 158 age- and gender-matched healthy control subjects were enrolled in the study. The SNPs were detected by the PCR-SSP (polymerase chain reaction-sequence specific primer) method. Results revealed that only IL4-1098, IL4-590, IL4-33, and IL10-592 SNP allele and/or genotype frequencies showed a significant variation between MS patients and control. At the haplotype level, the estimated frequency of TCC (IL4-1098-IL4-590-IL4-33) and GCC (IL10-1082-IL10-819-IL10-592) haplotypes was significantly increased in patients compared to control (TCC: 63.2 vs. 48.0%; odds ratio = 2.81; 95% confidence interval = 1.86-4.25; pc = 5.0 × 10-6; GCC 39.0 vs. 22.2%; odds ratio = 2.24; 95% confidence interval = 1.45-3.46; pc = 0.002). In conclusion, IL4 and IL10 genes harbor important SNPs that may confer MS susceptibility. In addition, their role in reducing the risk of disease is also suggested. However, the susceptibility of the investigated role can be better evaluated in terms of haplotype frequencies.

Entities:  

Keywords:  Haplotype; IL-10; IL-4; Polymorphism; Relapsing-remitting multiple sclerosis

Mesh:

Substances:

Year:  2019        PMID: 31264107     DOI: 10.1007/s10072-019-04000-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  27 in total

1.  Cytokine gene polymorphisms: methods of detection and biological significance.

Authors:  Gurvinder Kaur; Narinder Mehra
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Autoimmunity in multiple sclerosis: role of sphingolipids, invariant NKT cells and other immune elements in control of inflammation and neurodegeneration.

Authors:  Maria Podbielska; Joan O'Keeffe; Edward L Hogan
Journal:  J Neurol Sci       Date:  2017-12-22       Impact factor: 3.181

3.  Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis.

Authors:  C Pickard; C Mann; P Sinnott; M Boggild; C Hawkins; R C Strange; I V Hutchinson; W E Ollier; R P Donn
Journal:  J Neuroimmunol       Date:  1999-11-15       Impact factor: 3.478

Review 4.  Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.

Authors:  Fan Su; Feng Bai; Zhijun Zhang
Journal:  Neurosci Bull       Date:  2016-08-27       Impact factor: 5.203

5.  Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies.

Authors:  Alison L Van Dyke; Michele L Cote; Angie S Wenzlaff; Susan Land; Ann G Schwartz
Journal:  Cytokine       Date:  2009-04-07       Impact factor: 3.861

6.  Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.

Authors:  Ana Paula Kallaur; Edna Maria Vissoci Reiche; Sayonara Rangel Oliveira; Andrea Name Colado Simão; Wildea Lice de Carvalho Jennings Pereira; Daniela Frizon Alfieri; Tamires Flauzino; Caio de Meleck Proença; Marcell Alysson Batisti Lozovoy; Damacio Ramón Kaimen-Maciel; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

Review 7.  Revised diagnostic criteria of multiple sclerosis.

Authors:  Ron Milo; Ariel Miller
Journal:  Autoimmun Rev       Date:  2014-01-12       Impact factor: 9.754

8.  Distribution of 22 cytokine gene polymorphisms in Roma from the Republic of Macedonia.

Authors:  Dejan Trajkov; Aleksandar Petlichkovski; Olivija Efinska-Mladenovska; Slavica Hristomanova; Eli Djulejic; Meri Kirijas; Aleksandar Senev; Mirko Spiroski
Journal:  Iran J Allergy Asthma Immunol       Date:  2012-12       Impact factor: 1.464

Review 9.  Relationship between the IL-4 gene promoter -590C/T (rs2243250) polymorphism and susceptibility to autoimmune diseases: a meta-analysis.

Authors:  L-J Qiu; J Ni; H Cen; P-F Wen; M Zhang; Y Liang; H-F Pan; C Mao; D-Q Ye
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-03-14       Impact factor: 6.166

Review 10.  Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.

Authors:  Pushpalatha Palle; Kelly L Monaghan; Sarah M Milne; Edwin C K Wan
Journal:  Med Sci (Basel)       Date:  2017-10-13
View more
  5 in total

Review 1.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

Review 2.  The role of melatonin in Multiple Sclerosis.

Authors:  Charalampos Skarlis; Maria Anagnostouli
Journal:  Neurol Sci       Date:  2019-12-16       Impact factor: 3.307

3.  IL-10 Gene Polymorphisms and IL-10 Serum Levels in Patients with Multiple Sclerosis in Lithuania.

Authors:  Ugne Masilionyte; Greta Gedvilaite; Kriste Kaikaryte; Alvita Vilkeviciute; Loresa Kriauciuniene; Brigita Glebauskiene; Renata Balnyte; Rasa Liutkeviciene
Journal:  Brain Sci       Date:  2022-06-18

4.  Association of Polymorphisms in Inflammatory Cytokines Encoding Genes With Anti-N-methyl-D-Aspartate Receptor Encephalitis in the Southern Han Chinese.

Authors:  Xing Li; Jiajia Zhu; Yu Peng; Hongbing Guan; Jinyu Chen; Zhanhang Wang; Dong Zheng; Nan Cheng; Honghao Wang
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

5.  STAT3 and NTRK2 Genes Predicted by the Bioinformatics Approach May Play Important Roles in the Pathogenesis of Multiple Sclerosis and Obsessive-Compulsive Disorder.

Authors:  Ali Sepehrinezhad; Ali Shahbazi; Ali Bozorgmehr; Babak Kateb; Vicky Yamamoto; Sajad Sahab Negah
Journal:  J Pers Med       Date:  2022-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.